Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-27 @ 10:59 PM
Study NCT ID:
NCT04882293
Status:
UNKNOWN
Last Update Posted:
2022-03-02
First Post:
2021-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
Sponsor:
Laboratorios Silanes S.A. de C.V.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-05
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-29
First Submit QC Date:
None
Study First Post Date:
2021-05-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-28
Last Update Post Date:
2022-03-02
Last Update Post Date Type:
ACTUAL